IL-6 mediates defense against influenza virus by promoting protective antibody responses but not innate inflammation
Open Access
- 18 February 2025
- journal article
- Published by Elsevier in Mucosal Immunology
- Vol. 18 (3) , 596-606
Abstract
No abstract availableKeywords
Funding Information
- Eidgenössische Technische Hochschule Zürich
- ETH Zürich Foundation
This publication has 60 references indexed in Scilit:
- Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?Drugs, 2022
- Role of IL-6 in the commitment of T cell subsetsCytokine, 2021
- Targeting Interleukin-6 Signaling in ClinicImmunity, 2019
- The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibitionCurrent Opinion in Immunology, 2015
- Interleukin‐6 limits influenza‐induced inflammation and protects against fatal lung pathologyEuropean Journal of Immunology, 2013
- The pro- and anti-inflammatory properties of the cytokine interleukin-6Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Generation of T Follicular Helper Cells Is Mediated by Interleukin-21 but Independent of T Helper 1, 2, or 17 Cell LineagesImmunity, 2008
- Influenza virus: a novel method to assess viral and neutralizing antibody titers in vitroJournal of Immunological Methods, 1999
- IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitisEuropean Journal of Immunology, 1998
- Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic systemImmunity, 1994